Clinical Value of 131I in Diagnosis and Treatment of Recurrent Papillary Thyroid Carcinoma
The papillary thyroid cancer (PTC) patients have general good prognosis, but the relapse occurred in 20%-30% patients after initial treatment, which resulted in poor prognosis and treatment difficulty. 131I can act as a part of postoperative adjuvant therapy for the initial standard treatment of mid...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Magazine House of Cancer Research on Prevention and Treatment
2022-06-01
|
| Series: | Zhongliu Fangzhi Yanjiu |
| Subjects: | |
| Online Access: | http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.21.1214 |